GSK, Reckitt are the Only Suitors for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:February 4, 2018 Post category:BioPharma Companies including Sanofi, J&J, Nestle have dropped out. Source: BioSpace You Might Also Like Genentech Gets a Phase III Win With Hemophila A Drug Hemlibra November 19, 2017 <b>GE Ventures</b>, <b>Mayo Clinic Ventures</b> And <b>DFJ</b> Invest $13.75 Million In First Software Platform To Accelerate Cancer Cure Process And Delivery June 19, 2017 Arcus Biosciences, Wuxi Biologics Hammer Out R&D Cancer Pact Worth $816 Million+ August 16, 2017
<b>GE Ventures</b>, <b>Mayo Clinic Ventures</b> And <b>DFJ</b> Invest $13.75 Million In First Software Platform To Accelerate Cancer Cure Process And Delivery June 19, 2017
